{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:38:38Z","timestamp":1790091518576,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Interline Endowment Grant"},{"name":"Baptist Health Foundation of Jacksonville"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.wneu.2018.11.157","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T13:01:45Z","timestamp":1543237305000},"page":"435-442.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review"],"prefix":"10.1016","volume":"123","author":[{"given":"Pedro","family":"Aguilar-Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhuti","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Hanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp R.","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.11.157_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/088307389300800308","article-title":"Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage","volume":"8","author":"Broderick","year":"1993","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.wneu.2018.11.157_bib2","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2018.11.157_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.21476","article-title":"The excess burden of stroke in hospitalized adults with sickle cell disease","volume":"84","author":"Strouse","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.wneu.2018.11.157_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2018.11.157_bib5","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2018.11.157_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2018.11.157_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2018.11.157_bib8","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2018.11.157_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2013-12-545186","article-title":"Magnetic resonance imaging\/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2018.11.157_bib10","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2018.11.157_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0887-8994(96)00045-8","article-title":"Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease","volume":"14","author":"Vernet","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.wneu.2018.11.157_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0887-8994(03)00047-X","article-title":"Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure","volume":"29","author":"Fryer","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.wneu.2018.11.157_bib13","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2013.10.FOCUS13405","article-title":"Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases","volume":"36","author":"Kennedy","year":"2014","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2018.11.157_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3171\/2014.12.PEDS14522","article-title":"Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease","volume":"16","author":"Griessenauer","year":"2015","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.wneu.2018.11.157_bib15","doi-asserted-by":"crossref","unstructured":"Alamri A, Hever P, Cheserem J, Gradil C, Bassi S, Tolias CM. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease [e-pub ahead of print]. Br J Neurosurg. https:\/\/doi.org\/10.1080\/02688697.2017.1339227. accessed July 18, 2017.","DOI":"10.1080\/02688697.2017.1339227"},{"key":"10.1016\/j.wneu.2018.11.157_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/08880018.2017.1313917","article-title":"Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: single-institution experience","volume":"34","author":"Winstead","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.wneu.2018.11.157_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3171\/2017.1.PEDS16576","article-title":"Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome","volume":"20","author":"Yang","year":"2017","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.wneu.2018.11.157_bib18","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2009.01.FOCUS08307","article-title":"Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome","volume":"26","author":"Smith","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2018.11.157_bib19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pbc.26022","article-title":"Reduction in overt and silent stroke recurrence rate following cerebral revascularization surgery in children with sickle cell disease and severe cerebral vasculopathy","volume":"63","author":"Hall","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2018.11.157_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3171\/PED\/2008\/1\/3\/211","article-title":"Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis","volume":"1","author":"Hankinson","year":"2008","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.wneu.2018.11.157_bib21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2018.11.157_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jrsm.1160","article-title":"Get real in individual participant data (IPD) meta-analysis: a review of the methodology","volume":"6","author":"Debray","year":"2015","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.wneu.2018.11.157_bib23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jclinepi.2015.05.024","article-title":"How individual participant data meta-analyses have influenced trial design, conduct, and analysis","volume":"68","author":"Tierney","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.wneu.2018.11.157_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2013a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.wneu.2018.11.157_bib25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2018.11.157_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0090-3019(81)80017-1","article-title":"A\u00a0new surgical treatment of moyamoya disease in children: a preliminary report","volume":"15","author":"Matsushima","year":"1981","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2018.11.157_bib27","first-page":"155","article-title":"Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms","volume":"11","author":"Matsushima","year":"1984","journal-title":"Childs Brain"},{"key":"10.1016\/j.wneu.2018.11.157_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00381-004-1118-9","article-title":"Revascularisation surgery for paediatric moyamoya: a review of the literature","volume":"21","author":"Fung","year":"2005","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.wneu.2018.11.157_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s007010050035","article-title":"Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease?","volume":"142","author":"Houkin","year":"2000","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2018.11.157_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mpd.2002.122498","article-title":"Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke","volume":"140","author":"Scothorn","year":"2002","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.wneu.2018.11.157_bib31","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2018.11.157_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.1999.01127.x","article-title":"Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance","volume":"104","author":"Castellino","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.wneu.2018.11.157_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood.V96.1.76","article-title":"Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy","volume":"96","author":"Harmatz","year":"2000","journal-title":"Blood"},{"issue":"1 suppl 1","key":"10.1016\/j.wneu.2018.11.157_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0037-1963(01)90058-7","article-title":"Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease","volume":"38","author":"Ballas","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.wneu.2018.11.157_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/pbc.23145","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload","volume":"57","author":"Ware","year":"2011","journal-title":"Pediatr Blood Cancer"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018327165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018327165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T23:18:53Z","timestamp":1571959133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018327165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":35,"alternative-id":["S1878875018327165"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.11.157","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.11.157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}